About Snj Labs Private Limited
Data last updated: 05 January 2026
Snj Labs Private Limited is a private limited company based in Rajkot, Gujarat, India. It specialises in api manufacturers, a part of the broader pharmaceuticals sector. Incorporated on 19 December 2013, the company has been in operation for over 13 years.
Registered with ROC Ahmedabad under CIN U24233GJ2013PTC077965.
Capital: an authorised share capital of ₹40 Cr and a paid-up capital of ₹30.48 Cr. It is led by directors including Suresh Devjibhai Sorathiya and Nandlal Vitthalbhai Shekhada.
Last AGM: 30 September 2024. Financial statements filed for year ended 31 March 2024. Office: Survey No. 137 Plot No. 5 To 16 At Padvala Tal. Kotda Sangani, Rajkot, Gujarat, India – 360024.
As per the financials filed for FY 2025, the company reported a revenue of ₹83.01 Cr, a growth of 28% compared to the previous year.
The company has a workforce of approximately 170 employees as per the latest available data. Its group structure includes 1 subsidiary.
The company is associated with 1 brand - Snj Labs. As per MCA filings, the company has open charges of ₹100.01 Cr and satisfied charges of ₹2.26 Cr on record.
The current compliance status is marked as compliant by the Registrar of Companies. For more details, the company can be reached via its website snjlabs.com.
-
Email*****@*****.com
-
Telephone+91-****-******
-
Website
-
Social Media
-
Registered AddressSurvey No. 137 Plot No. 5 To 16 At Padvala Tal. Kotda Sangani, Rajkot, Gujarat, India – 360024
-
IndustryPharma, API Manufacturers
- Historical Financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Litigation, compliance and MCA filings
- PDF report delivered after checkout
Associated Brands with Snj Labs Private Limited
Snj Labs Private Limited operates one associated brand: SNJ Labs. These brands represent Snj Labs Private Limited's diversified market presence and brand portfolio.
| Brand | Description | Website |
|---|---|---|
| API manufacturing and drug intermediates production in India. | snjlabs.com |
Business Activity of Snj Labs Private Limited
Snj Labs Private Limited is engaged in the principal business activity of manufacturing, with detailed activities including chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products.
| Main Activity Group Code | Description of Main Activity | Business Activity Code | Description of Business Activity | Turnover Percentage |
|---|---|---|---|---|
| C | Manufacturing | C6 | Chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products | ********* |
Auditor Details of Snj Labs Private Limited
Snj Labs Private Limited is audited by Ramesh M Patel & Co for the financial year 2024. The auditor plays a crucial role in ensuring financial transparency and compliance with accounting standards.
| Name | Status | Appointment Date | Cessation Date |
|---|---|---|---|
| Ramesh M Patel & Co | blur-value | blur-value | blur-value |
Board of Directors of Snj Labs Private Limited
Snj Labs Private Limited is governed by 5 directors who oversee the company's operations and strategic decisions.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
|
Suresh Devjibhai Sorathiya
Also directs:
Skywin Spinning Private Limited, Earth Spintex Private Limited, Snj Lifecare Private Limited and 5 more
|
Director | 19 Dec 2013 | 12 Years 6 Months | Current |
|
Nandlal Vitthalbhai Shekhada
Also directs:
Nes Wellness Foundation, Sucralfa Remedies Private Limited
|
Director | 19 Dec 2013 | 12 Years 6 Months | Current |
|
Jigneshkumar Devrajbhai Akbari
Also directs:
Snj Lifecare Private Limited, Endoc Biotech Private Limited, Pmech Engitech Private Limited and 1 more
|
Director | 19 Dec 2013 | 12 Years 6 Months | Current |
|
Ranjanben Sureshbhai Sorathiya
Also directs:
Nira Life Sciences Private Limited
|
Director | 19 Dec 2013 | 12 Years 6 Months | Current |
Financials of Snj Labs Private Limited FY 2024 filings available
Snj Labs Private Limited reported revenue of ₹83.01 Cr (up 28% YoY) for FY 2025. Profit growth despite declining revenue indicates effective cost management and margin discipline.
| Metrics | ***** | ***** | ***** | ***** | ***** |
|---|---|---|---|---|---|
| Revenue | |||||
| Revenue from Operations | ***** | ***** | ***** | ***** | ***** |
| Revenue Growth % | ***** | ***** | ***** | ***** | ***** |
| Other Income | ***** | ***** | ***** | ***** | ***** |
| Total Revenue | ***** | ***** | ***** | ***** | ***** |
| Expenses | |||||
| Total Expenses | ***** | ***** | ***** | ***** | ***** |
| Raw Material Cost | ***** | ***** | ***** | ***** | ***** |
| Change in Inventory FG | ***** | ***** | ***** | ***** | ***** |
| Change in Inventory WIP | ***** | ***** | ***** | ***** | ***** |
| Purchase of Traded Goods | ***** | ***** | ***** | ***** | ***** |
| Employee Cost | ***** | ***** | ***** | ***** | ***** |
| Managerial Remuneration | ***** | ***** | ***** | ***** | ***** |
| Audit Fees | ***** | ***** | ***** | ***** | ***** |
| Insurance | ***** | ***** | ***** | ***** | ***** |
| Power & Fuel | ***** | ***** | ***** | ***** | ***** |
| Interest | ***** | ***** | ***** | ***** | ***** |
| Depreciation | ***** | ***** | ***** | ***** | ***** |
| Other Expenses | ***** | ***** | ***** | ***** | ***** |
| Profitability | |||||
| EBITDA (Operating Profit) | ***** | ***** | ***** | ***** | ***** |
| Operating Margin % | ***** | ***** | ***** | ***** | ***** |
| Exceptional Items | ***** | ***** | ***** | ***** | ***** |
| Extraordinary Items | ***** | ***** | ***** | ***** | ***** |
| Profit Before Exceptional & Extraordinary Items | ***** | ***** | ***** | ***** | ***** |
| Profit Before Tax | ***** | ***** | ***** | ***** | ***** |
| Tax & Net Profit | |||||
| Tax Expense | ***** | ***** | ***** | ***** | ***** |
| Current Tax | ***** | ***** | ***** | ***** | ***** |
| Deferred Tax | ***** | ***** | ***** | ***** | ***** |
| Profit from Discontinued Operations | ***** | ***** | ***** | ***** | ***** |
| Tax on Discontinued Operations | ***** | ***** | ***** | ***** | ***** |
| Profit | ***** | ***** | ***** | ***** | ***** |
| Net Margin % | ***** | ***** | ***** | ***** | ***** |
| Metrics | ***** | ***** | ***** | ***** | ***** |
|---|---|---|---|---|---|
| Shareholders' Funds | |||||
| Total Shareholders' Funds | ***** | ***** | ***** | ***** | ***** |
| Equity Capital | ***** | ***** | ***** | ***** | ***** |
| Reserves & Surplus | ***** | ***** | ***** | ***** | ***** |
| Money Against Warrants | ***** | ***** | ***** | ***** | ***** |
| Other Equity | ***** | ***** | ***** | ***** | ***** |
| Non-Current Liabilities | |||||
| Total Non-Current Liabilities | ***** | ***** | ***** | ***** | ***** |
| Long-Term Borrowings | ***** | ***** | ***** | ***** | ***** |
| Deferred Tax Liabilities | ***** | ***** | ***** | ***** | ***** |
| Other Non-Current Liabilities | ***** | ***** | ***** | ***** | ***** |
| Long-Term Provisions | ***** | ***** | ***** | ***** | ***** |
| Current Liabilities | |||||
| Total Current Liabilities | ***** | ***** | ***** | ***** | ***** |
| Short-Term Borrowings | ***** | ***** | ***** | ***** | ***** |
| Trade Payables | ***** | ***** | ***** | ***** | ***** |
| Other Current Liabilities | ***** | ***** | ***** | ***** | ***** |
| Short-Term Provisions | ***** | ***** | ***** | ***** | ***** |
| Total Equity & Liabilities | ***** | ***** | ***** | ***** | ***** |
| Non-Current Assets | |||||
| Non-Current Assets | ***** | ***** | ***** | ***** | ***** |
| Tangible Assets | ***** | ***** | ***** | ***** | ***** |
| Intangible Assets | ***** | ***** | ***** | ***** | ***** |
| Capital WIP | ***** | ***** | ***** | ***** | ***** |
| Intangibles Under Dev | ***** | ***** | ***** | ***** | ***** |
| Investments | ***** | ***** | ***** | ***** | ***** |
| Deferred Tax Assets | ***** | ***** | ***** | ***** | ***** |
| LT Loans & Advances | ***** | ***** | ***** | ***** | ***** |
| Other Non-Current Assets | ***** | ***** | ***** | ***** | ***** |
| Current Assets | |||||
| Current Assets | ***** | ***** | ***** | ***** | ***** |
| Current Investments | ***** | ***** | ***** | ***** | ***** |
| Inventories | ***** | ***** | ***** | ***** | ***** |
| Trade Receivables | ***** | ***** | ***** | ***** | ***** |
| Cash & Bank Balance | ***** | ***** | ***** | ***** | ***** |
| ST Loans & Advances | ***** | ***** | ***** | ***** | ***** |
| Other Current Assets | ***** | ***** | ***** | ***** | ***** |
| Total Assets | ***** | ***** | ***** | ***** | ***** |
| Metrics | ***** | ***** | ***** | ***** | ***** |
|---|---|---|---|---|---|
| Cash from Operating Activities (CFO) | |||||
| Profit Before Tax | ***** | ***** | ***** | ***** | ***** |
| Non-Cash Adjustments | ***** | ***** | ***** | ***** | ***** |
| + Interest Expense | ***** | ***** | ***** | ***** | ***** |
| + Depreciation | ***** | ***** | ***** | ***** | ***** |
| +/- Unrealized Forex | ***** | ***** | ***** | ***** | ***** |
| - Dividend Income | ***** | ***** | ***** | ***** | ***** |
| - Interest Income | ***** | ***** | ***** | ***** | ***** |
| +/- Other Non-Cash Items | ***** | ***** | ***** | ***** | ***** |
| Changes in Working Capital | ***** | ***** | ***** | ***** | ***** |
| +/- Inventory | ***** | ***** | ***** | ***** | ***** |
| +/- Debtors | ***** | ***** | ***** | ***** | ***** |
| +/- Creditors | ***** | ***** | ***** | ***** | ***** |
| Reconciliation Adjustments | ***** | ***** | ***** | ***** | ***** |
| Cash Generated from Operations | ***** | ***** | ***** | ***** | ***** |
| Income Taxes Paid | ***** | ***** | ***** | ***** | ***** |
| Net CFO (Cash from Operations) | ***** | ***** | ***** | ***** | ***** |
| Cash from Investing Activities (CFI) | |||||
| Acquisitions & Disposals | ***** | ***** | ***** | ***** | ***** |
| Disposal of Subsidiaries | ***** | ***** | ***** | ***** | ***** |
| Acquisition of Subsidiaries | ***** | ***** | ***** | ***** | ***** |
| Capex | ***** | ***** | ***** | ***** | ***** |
| Purchase of Fixed Assets | ***** | ***** | ***** | ***** | ***** |
| Sale of Fixed Assets | ***** | ***** | ***** | ***** | ***** |
| Other Investing Cash Flows | ***** | ***** | ***** | ***** | ***** |
| Net CFI (Cash from Investing) | ***** | ***** | ***** | ***** | ***** |
| Cash from Financing Activities (CFF) | |||||
| Equity Issuance | ***** | ***** | ***** | ***** | ***** |
| Debt Raised | ***** | ***** | ***** | ***** | ***** |
| Debt Repaid | ***** | ***** | ***** | ***** | ***** |
| Dividends Paid | ***** | ***** | ***** | ***** | ***** |
| Interest Paid | ***** | ***** | ***** | ***** | ***** |
| Net CFF (Cash from Financing) | ***** | ***** | ***** | ***** | ***** |
| Net Cash Position | |||||
| Net Change in Cash (Pre-Forex) | ***** | ***** | ***** | ***** | ***** |
| Closing Cash & Equivalents | ***** | ***** | ***** | ***** | ***** |
| Metrics | ***** | ***** | ***** | ***** | ***** |
|---|---|---|---|---|---|
| Liquidity | |||||
| Current Ratio | ***** | ***** | ***** | ***** | ***** |
| Quick Ratio | ***** | ***** | ***** | ***** | ***** |
| Cash Ratio | ***** | ***** | ***** | ***** | ***** |
| Efficiency | |||||
| Inventory Days | ***** | ***** | ***** | ***** | ***** |
| Debtor Days | ***** | ***** | ***** | ***** | ***** |
| Creditor Days | ***** | ***** | ***** | ***** | ***** |
| Cash Conversion Cycle | ***** | ***** | ***** | ***** | ***** |
| Asset Turnover | ***** | ***** | ***** | ***** | ***** |
| Profitability | |||||
| Net Profit Margin % | ***** | ***** | ***** | ***** | ***** |
| Operating Margin % | ***** | ***** | ***** | ***** | ***** |
| ROE % | ***** | ***** | ***** | ***** | ***** |
| ROCE % | ***** | ***** | ***** | ***** | ***** |
| Net Worth Margin % | ***** | ***** | ***** | ***** | ***** |
| Growth | |||||
| Revenue Growth % | ***** | ***** | ***** | ***** | ***** |
| Leverage | |||||
| Equity Multiplier | ***** | ***** | ***** | ***** | ***** |
| Debt / EBITDA | ***** | ***** | ***** | ***** | ***** |
| Solvency | |||||
| D/E Ratio | ***** | ***** | ***** | ***** | ***** |
| ICR | ***** | ***** | ***** | ***** | ***** |
Consolidated Statements
Income Statement, Balance Sheet, Cash Flow & Ratios available in the full report.
Shareholding Pattern of Snj Labs Private Limited
As of FY 2024, Snj Labs Private Limited's shareholding pattern shows 86.13% by promoters, 13.87% by public shareholders. The promoters hold a majority stake, indicating strong promoter control.
| Year | 2025 |
|---|---|
| Promoters | 33.19% |
| DII | 23.22% |
| FII | 18.28% |
| Public | 22.89% |
| Others | 2.42% |
Group Structure of Snj Labs Private Limited
Snj Labs Private Limited has 1 subsidiary company and 1 associated company. This group structure data is as of FY 2024. The corporate group structure reflects Snj Labs Private Limited's business expansion strategy and organizational complexity.
| Company Name | CIN | Shares Held |
|---|---|---|
| Snj Pmech Private Limited | U29297GJ2022PTC136369 |
**.**%
|
Showing major subsidiaries. Total: 1.
Charges & Borrowings of Snj Labs Private Limited
| Date | Lender | Amount | Status |
|---|---|---|---|
| 08 Oct 2025 | Axis Bank Limited | ₹58.67 Cr | Open |
| 08 Sep 2025 | Hdfc Bank Limited | ₹22 Lakh | Open |
| 20 May 2025 | Others | ₹18.6 Lakh | Open |
| 22 Nov 2024 | Others | ₹14 Lakh | Open |
| 23 Oct 2024 | Hdfc Bank Limited | ₹8.7 Lakh | Open |
Total charge records: 13 View all charges
Employees and EPFO Compliance at Snj Labs Private Limited
Snj Labs Private Limited has a workforce of 170 employees as of Oct 08, 2025.
Employee Count & EPFO Data of Snj Labs Private Limited
Access employee headcount trends, monthly PF payment records, EPFO establishment details, and compliance data.
GST Compliance of Snj Labs Private Limited
GSTIN & GST Filing Data of Snj Labs Private Limited
Access GSTIN registrations, state-wise filing compliance, HSN/SAC codes, and detailed goods & services data.
Credit Ratings, Litigation & Regulatory Alerts for Snj Labs Private Limited
Credit Ratings, Legal Cases & Regulatory Alerts of Snj Labs Private Limited
Access complete credit rating history, litigation records, regulatory alerts, and compliance data.
MSME Payment Delays by Snj Labs Private Limited
MSME Payment Delays by Snj Labs Private Limited
Track payments outstanding to micro and small enterprise vendors, as disclosed in half-yearly MSME-1 returns filed with the MCA.
Subsidiaries & Group Companies of Snj Labs Private Limited
Subsidiaries & Group Companies of Snj Labs Private Limited
See the full corporate group - holding company, subsidiaries, associates and joint ventures of Snj Labs Private Limited with ownership details.
MCA Filings & Documents of Snj Labs Private Limited
MCA Filings & Documents of Snj Labs Private Limited
Download official documents filed with the Ministry of Corporate Affairs - from incorporation papers to the latest annual filings.
Recent Activity on Snj Labs Private Limited
Frequently Asked Questions about Snj Labs Private Limited
Snj Labs Private Limited is an active private limited company in the pharma sector based in Rajkot, Gujarat, India. It was incorporated on 19 December 2013 (13+ years old) and is registered under CIN U24233GJ2013PTC077965. The company has 170 employees.
Snj Labs Private Limited reported revenue of ₹83.01 Cr for FY 2025 (up 28.00% YoY).
The current directors of Snj Labs Private Limited are:
The primary industry of Snj Labs Private Limited is pharma. The company specifically operates in api manufacturers. The company is currently active in this sector.
Snj Labs Private Limited can be reached at the registered office: Survey No. 137 Plot No. 5 To 16 At Padvala Tal. Kotda Sangani, Rajkot, Gujarat, India – 360024, or through the website snjlabs.com.
The authorised capital is ₹40 Cr, and the paid-up capital is ₹30.48 Cr.